FundedIQ
Biotechnology

VU: Funding, Investors & Team (Sep 2026)

VU is a company that focuses specifically on preventing fraud and safeguarding people's identities through cybersecurity measures. They have developed unique methods of identity authentication incorporating biometrics, geolocation, machine learning, ID card recognition, and analysis of user behavior.

www.vusecurity.com LinkedIn Buenos Aires, Argentina 101-250 employees
Biometrics Cyber Security Fraud Detection Identity Management Security Fraud analysis Authentication Token
Total raised
$4.2M
Rounds
1
Latest
Undisclosed round
Apr 2023

VU has raised $4.2M across 1 funding round on record, the most recent an undisclosed round of $4.2M announced in Apr 2023.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

VU Company Profile and Key Stats

Total funding raised
$4.2M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$4.2M in Apr 2023
Employees
101-250
reported band
Headquarters
Buenos Aires, Argentina

Latest funding round on record: Apr 2023.

VU Funding Rounds

Date
Round
Amount
Undisclosed round
$4.2M

VU Founders and Leadership Team

Name
Role
Contact
Sebastian Stranieri
CEO
Locked

Contact details for the VU team: 1 of 1 has an email address on file.

Start 14-day free trial →

VU Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
86
$2.2M

VU's latest round of $4.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like VU in Biotechnology and Buenos Aires

Companies Similar to VU

BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient…

Series A $8.0M

Kresko RNAtech is a biotechnology company that offers services for the development and manufacturing of…

Undisclosed round $40k

Bioeutectics is committed to improving the sustainability of industrial products and processes by providing…

Seed $2.1M

Mycorium Biotech is a biotechnology startup committed to creating sustainable and eco-friendly materials for…

Pre-Seed $250k

We are a biotech startup democratizing genomic sequencing applications with proprietary technology. We…

Undisclosed round $100k

Founded in 2016, Bioheuris develops sustainable weed management systems. The company integrates synthetic…

Undisclosed round $2.0M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…

Seed $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…

Series A $40.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and…

Series B $15.5M

VU Funding FAQs

What does VU do?

VU is a company that focuses specifically on preventing fraud and safeguarding people's identities through cybersecurity measures. They have developed unique methods of identity authentication incorporating biometrics, geolocation, machine learning, ID card recognition, and analysis of user behavior.

How much funding has VU raised?

VU has raised $4.2M across 1 round on record. The most recent is an undisclosed round of $4.2M announced in Apr 2023.

When did VU last raise funding?

VU's most recent funding round on record is an undisclosed round of $4.2M, announced in Apr 2023.

Who is the CEO of VU?

Sebastian Stranieri is listed as CEO at VU.

Where is VU headquartered?

VU is based in Buenos Aires, Distrito Federal, Argentina.

How many employees does VU have?

VU is in the 101-250 employee band.

How does VU's funding compare to other Biotechnology startups?

VU's latest round of $4.2M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's VU Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for VU is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.